董家志,黄德尧,黄玉德.脑膜瘤组织中相关分子标志物表达与预后的关系.[J].中南医学科学杂志.,2019,(1):25-29.
脑膜瘤组织中相关分子标志物表达与预后的关系
Relationship between expression of related molecular markers and prognosis in meningioma tissues
投稿时间:2018-05-25  修订日期:2018-10-18
DOI:10.15972/j.cnki.43-1509/r.2019.01.006
中文关键词:  脑膜瘤  上皮细胞激酶  管上皮钙黏附素  骨膜蛋白  预后
英文关键词:meningioma  EphA2  VE-cadherin  PN  prognosis
基金项目:
作者单位
董家志 广元市第二人民医院神经外科,四川 广元 628017 
黄德尧 广元市第二人民医院神经外科,四川 广元 628017 
黄玉德 广元市第二人民医院神经外科,四川 广元 628017 
摘要点击次数: 604
全文下载次数: 493
中文摘要:
      为探讨脑膜瘤相关分子标志物(EphA2、VE-cadherin、PN)表达及其与脑膜瘤组织的病理级别、患者预后的关系,检测78例脑膜瘤患者病理组织及21例正常脑组织中EphA2、VE-cadherin、PN表达及蛋白相对表达量。分析其表达的相关性及与脑膜瘤组织病理级别、患者预后的关系。结果显示,脑膜瘤组织中EphA2、VE-cadherin、PN阳性表达率均高于正常脑组织,且与脑膜瘤病理分级呈正相关。脑膜瘤组织中EphA2、VE-cadherin、PN表达任意两者之间均呈正相关。脑膜瘤组织中EphA2、VE-cadherin、PN不同表达程度的患者5年复发率存在差异。结果提示,脑膜瘤相关分子标志物EphA2、VE-cadherin、PN在脑膜瘤患者中表达率均较高,且与脑膜瘤患者预后存在关联。
英文摘要:
      To study the relationship between the expressions of molecular markers, erythropoietin-producing hepatocellular receptor A2 (EphA2), vascular endothelial cadherin(VE-cadherin), Periostin(PN) and the pathological grade and prognosis, 78 patients with meningioma and normalbrain tissue were used to detect the expressions of EphA2, VE-cadherin and PN. The correlation between the expression of EphA2, VE-cadherin and PN in meningioma and the relationship with the pathological grade and prognosis of meningiomas were analyzed. The results showed that the positive expression rates of EphA2, VE-cadherin, and PN were higher in meningiomas than in normal brain tissues, and were positively correlated with the pathological grade of meningiomas. The five-year recurrence rate of patients with different expression levels of EphA2, VE-cadherin, and PN in meningioma was different. The results suggest that the positive expression rate of EphA2, VE-cadherin and PN was higher in meningioma tissues and are associated with the prognosis of meningiomas.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=62D14EE7494AD1D8857458E6E5EC52A7050E11592BFF0EDD844F0DA92DE874751C90FE93B4C9BCA10CC89E8CD20D94F51A39F9AD19CC40BFA1D90DA5903E1894C3EAFAE9AA5A05C187065FC67C0A2BF990E5F71156620CEEA90EF77A4F2A294281E3CBDAD7F42458&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=B6351343F4791CA3&aid=2BF99E2DE8AA5BC63C08174924118F4B&vid=&iid=CA4FD0336C81A37A&sid=C5154311167311FE&eid=771469D9D58C34FF&fileno=20190106&flag=1&is_more=0">